DOI Services Persistent Identifiers for Scholarly Research
You are viewing the preserved copy. Open the article on the journal's website →

International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-11

PHARMACOGENOMICS AND ITS ROLE IN PERSONALIZED MEDICINE DEVELOPMENT

  • Sana Afzal BS, Department of Computer Science, The Cosmic Degree College (For Women) ,University of Okara

Abstract

Pharmacogenomics has emerged as an important field in modern clinical pharmacology, focusing on the

relationship between genetic variations and individual responses to medications. It plays a significant role in

developing personalized medicine by helping healthcare professionals understand how genetic differences influence

drug metabolism, therapeutic effectiveness, treatment outcomes, and adverse drug reactions. Traditional medical

treatment generally follows standardized approaches, in which patients with similar conditions may receive

identical medications and dosages. However, individuals may respond differently to the same treatment because of

variations in their genetic makeup, biological characteristics, and metabolic processes. Pharmacogenomics

provides opportunities to improve treatment selection by identifying genetic factors that influence medication

responses and support individualized therapeutic decisions. Recent developments in genomic technologies,

molecular diagnostics, and clinical genetic testing have strengthened the application of pharmacogenomics in

healthcare. This research examines the role of pharmacogenomics in personalized medicine development, explores

its contribution to drug selection and dosage optimization, and evaluates its potential to improve patient safety and

therapeutic outcomes. The study adopts a qualitative research approach based on a review of recent scientific

literature and published research. The findings highlight that pharmacogenomics can contribute to more effective

treatment strategies, reduce preventable medication-related complications, and support evidence-based clinical

decision-making. However, challenges involving testing costs, clinical implementation, professional education,

ethical concerns, and genetic data privacy remain important considerations. The study concludes that integrating

pharmacogenomics into routine clinical practice can strengthen personalized healthcare and contribute to the

development of safer, more effective, and patient-centered medical treatments.

Record

Identifier
https://doi-services.com/1141/230
Published
2026-03-08
Version
1
Original
https://studentsconsultancyhome.com/season-2/journal/index.php/IJCPMS/article/view/230